UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Blood, 2022-03, Vol.139 (12), p.1863-1877

2022

Volltextzugriff (PDF)

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Molecular cancer therapeutics, 2023-11, Vol.22 (11), p.1319-1331

2023

Volltextzugriff (PDF)

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Annals of oncology, 2013-05, Vol.24 (5), p.1385-1392

2013

Volltextzugriff (PDF)

Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation

The EMBO journal, 1998-08, Vol.17 (15), p.4404-4413

1998

Volltextzugriff (PDF)

BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH‐RISK LARGE B‐CELL LYMPHOMA (NLG‐LBC‐06 PHASE II TRIAL): IMPACT OF CTDNA AND TP53 ABERRATIONS ON CLINICAL OUTCOME

Hematological oncology, 2023-06, Vol.41 (S2), p.51-52

2023

Volltextzugriff (PDF)

Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

Oncogene, 1999-11, Vol.18 (45), p.6158-6162

1999

Volltextzugriff (PDF)

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial

Blood advances, 2024-01, Vol.8 (2), p.407-415

2024

Volltextzugriff (PDF)

PROGNOSTIC VALUE OF BASELINE FDG PET PARAMETERS IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS

Hematological oncology, 2019-06, Vol.37 (S2), p.411-411

2019

Volltextzugriff (PDF)

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

Blood cancer journal (New York), 2016-11, Vol.6 (11), p.e501-e501

2016

Volltextzugriff (PDF)

E6 E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells

Oncogene, 2006-08, Vol.25 (35), p.4880-4889

2006

Volltextzugriff (PDF)

Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients

European journal of haematology, 2006-03, Vol.76 (3), p.245-250

2006

Volltextzugriff (PDF)

Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells

Molecular and Cellular Biology, 2001-07, Vol.21 (13), p.4369-4378

2001

Volltextzugriff (PDF)

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.405-410

2004

Volltextzugriff (PDF)

A PHASE 1/2 STUDY OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20+ TUMORS, RITUXIMAB IN PATIENTS WITH RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS—THE P[R]EBEN STUDY

Hematological oncology, 2017-06, Vol.35 (S2), p.423-424

2017

Volltextzugriff (PDF)

SAFETY RUN‐IN OF COPANLISIB IN COMBINATION WITH RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN'S LYMPHOMA

Hematological oncology, 2017-06, Vol.35 (S2), p.408-410

2017

Volltextzugriff (PDF)

CNS TARGETING CHEMOTHERAPY IS ASSOCIATED WITH SUPERIOR SURVIVAL IN PATIENTS WITH TESTICULAR LYMPHOMA – RESULTS FROM FINNISH–DANISH RETROSPECTIVE STUDY

Hematological oncology, 2017-06, Vol.35 (S2), p.379-379

2017

Volltextzugriff (PDF)

Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (4), p.367-372

2006

Volltextzugriff (PDF)

DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES

Hematological oncology, 2017-06, Vol.35 (S2), p.199-200

2017

Volltextzugriff (PDF)

Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

European journal of cancer (1990), 2019-07, Vol.115, p.27-36

2019

Volltextzugriff (PDF)

Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients

European journal of haematology, 2004-09, Vol.73 (3), p.174-178

2004

Volltextzugriff (PDF)

COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)

Hematological oncology, 2017-06, Vol.35 (S2), p.119-120

2017

Volltextzugriff (PDF)

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

Neurology, 2016-11, Vol.87 (22), p.2290-2299

2016

Volltextzugriff (PDF)

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2008-07, Vol.42 (2), p.93-98

2008

Volltextzugriff (PDF)

PD-L1 + tumor-associated macrophages and PD-1 + tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma

Haematologica (Roma), 2018-11, Vol.103 (11), p.1908-1914

2018

Volltextzugriff (PDF)

Heat Shock Response - Pathophysiological Implications

Annals of medicine (Helsinki), 1997-02, Vol.29 (1), p.73-78

1997

Volltextzugriff (PDF)

1 – 25 von 545

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(511)
Mit Volltextzugriff
(455)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(222)
Humans
(155)
Female
(83)
Male
(82)
Hematology
(66)
Medicin Och Hälsovetenskap
(64)
Middle Aged
(59)
Aged
(58)
Oncology
(58)
Adult
(54)
Lymphoma
(49)
Animals
(41)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(36)
Biological And Medical Sciences
(36)
Prognosis
(35)
Aged, 80 And Over
(27)
Biochemistry & Molecular Biology
(26)
Medical Sciences
(26)
Rituximab
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation

BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH‐RISK LARGE B‐CELL LYMPHOMA (NLG‐LBC‐06 PHASE II TRIAL): IMPACT OF CTDNA AND TP53 ABERRATIONS ON CLINICAL OUTCOME

Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial

PROGNOSTIC VALUE OF BASELINE FDG PET PARAMETERS IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

E6 E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells

Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients

Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey

A PHASE 1/2 STUDY OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20+ TUMORS, RITUXIMAB IN PATIENTS WITH RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS—THE P[R]EBEN STUDY

SAFETY RUN‐IN OF COPANLISIB IN COMBINATION WITH RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN'S LYMPHOMA

CNS TARGETING CHEMOTHERAPY IS ASSOCIATED WITH SUPERIOR SURVIVAL IN PATIENTS WITH TESTICULAR LYMPHOMA – RESULTS FROM FINNISH–DANISH RETROSPECTIVE STUDY

Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis

DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES

Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients

COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma

PD-L1 + tumor-associated macrophages and PD-1 + tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma

Heat Shock Response - Pathophysiological Implications

Suchergebnisse filtern